Introduction

ˇ§Tri-Iˇ¨ indicated ˇ§Ideal, Innovation, Integrationˇ¨

Found in April 2000, Tri-I Biotechˇ¦s capital is NT$ 20 million. The mission of Tri-I Biotech is to give a total solution services as a bridge between research labs and biotech pharmaceutical industries. In Jan. 2003, we aggrandized finance to NT$ 40 million. With experienced sales team, Tri-I Biotech is one of the most active genomics and proteomics companies in Taiwan.

Our Team

We are a group of experienced and aggressive people with life science, electronic engineering and computer background. There are 25 persons in our team.

Future of Company

 Tri-I Biotech will combine with these service centers. That will be a serial service from genomics to proteomics. The user can get a full service in life science area.

Tri-I Biotech will build a research and development team at end of the 2005. The team will focus on the drug discovery and diagnostic kit.